The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Interrupting HEG1/Cx43 interaction to promote cuproptosis via inhibiting gap junction to overcome glioblastoma radioresistance. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I.
Springbok Analytics, a life sciences muscle and analytics company, has received FDA 510(k) clearance for MuscleView, an AI-powered technology that analyzes muscle health via magnetic resonance (MR) ...
Innovation in the MRI market is centered around AI reconstruction, advanced magnet design, and workflow automation. AI-enabled reconstruction platforms are transforming imaging workflows by shortening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results